ENTPD1/CD39 is a promising therapeutic target in oncology.

Autor: Bastid, J1, Cottalorda-Regairaz, A1, Alberici, G1, Bonnefoy, N2, Eliaou, J-F3, Bensussan, A4
Zdroj: Oncogene. 4/4/2013, Vol. 32 Issue 14, p1743-1751. 9p.
Databáze: Academic Search Ultimate